← 產業報告目錄
Nucleic Acid Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Genetic Disorders, Infectious Diseases, Cancer, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others) By Region, And By Segment Forecasts, 2024-2031.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-22頁數 180報告編號 INSIGHTACE-70c2e21f2d
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Nucleic Acid Therapeutics Market on a global scale was estimated at USD 4.93 billion in 2023 and is expected to attain USD 13.86 billion by 2031, with a projected CAGR of 13.8% between 2024 and 2031.
Nucleic Acid Therapeutics encompasses challenges.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nucleic Acid Therapeutics Market Snapshot
Chapter 4. Global Nucleic Acid Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology& Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:
5.2.1. RNA targeted therapeutics
5.2.2. Gene Therapies
5.2.3. Epigenetic and microRNA modulating therapies
5.2.4. Genome editing therapies
5.2.5. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Autoimmune Disorders
6.2.2. Genetic Disorders
6.2.3. Infectious Diseases
6.2.4. Cancer
6.2.5. Others
Chapter 7. Market Segmentation 3: by End User Estimates & Trend Analysis
7.1. by End User & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
7.2.1. Hospitals & Clinics
7.2.2. Academic & Research Institutes
7.2.3. Others
Chapter 8. Nucleic Acid Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.1.2. North America Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.3. North America Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.1.4. North America Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.2.2. Europe Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.3. Europe Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.2.4. Europe Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.3.2. Asia Pacific Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.3. Asia-Pacific by End User, Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts 2024-2031
8.3.4. Asia Pacific Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.4.2. Latin America Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.3. Latin America Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.4.4. Latin America Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.5.2. Middle East & Africa Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.3. Middle East & Africa Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.5.4. Middle East & Africa Nucleic Acid Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Novartis
9.2.2. Moderna Inc
9.2.3. BioNTech
9.2.4. Arrowhead Pharmaceuticals
9.2.5. Merck
9.2.6. Thermo Fischer Scientific
9.2.7. Sanofi
9.2.8. Alnylam Pharmaceuticals
9.2.9. Sarepta Therapeutics
9.2.10. Qiagen
9.2.11. Imugene
9.2.12. Copernicus Therapeutics Inc.
9.2.13. Protagonist Therapeutics
9.2.14. Arbutus Biopharma
9.2.15. Agilent Technologies
9.2.16. Silence Therapeutics (UK),
9.2.17. Astellas Pharma Inc. (Japan),
9.2.18. CureVac SE (Germany),
9.2.19. Sirnaomics (US),
9.2.20. Arcturus Therapeutics Inc. (US)
9.2.21. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們